Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease
- 31 December 2003
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 146 (6), 1022-1027
- https://doi.org/10.1016/s0002-8703(03)00443-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart FailureCirculation, 1999
- Candesartan CilexetilDrugs, 1998
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial InfarctionNew England Journal of Medicine, 1995
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991